Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
12/2010
12/08/2010CN101073625B Medicinal composition with anti-infective and anti-inflammatory functions
12/08/2010CN101053556B Water soluble coenzyme Q10 hydroxyl-beta-cyclodextrin inclusion compound and its preparation method
12/08/2010CN101050177B Black purple Tuowusu A and medical application in restraining grampostive bacteria
12/08/2010CN101031572B (R/S) rifamycin derivatives, their preparation and pharmaceutical compositions
12/08/2010CN101022779B Antifungal drug delivery
12/08/2010CN101007130B An antibiotic and anti-inflammation traditional Chinese medicine composition and its preparation method
12/08/2010CN100998575B Finger nail coating agent of antifungal agent and its preparing method
12/07/2010US7846937 such as 1-amino-cyclopropanecarboxylic acid 2-(2-amino-6-oxo-1,6-dihydro-purin-9-ylmethoxy)-ethyl ester, having unexpected stability to acid and base conditions, used for treating hepes infections; acylating acyclovir with 1-tert-butoxycarbonylamino-cyclopropanecarboxylic acid, the deprotecting the amine
12/07/2010US7846925 such as 5-(1,3-benzodioxol-5-ylmethylene)-1,3-thiazolidine-2,4-dione, used for the treatment and/or prophylaxis of autoimmune, cardiovascular or neurodegenerative disorders, inflammatory or kidney diseases, bacterial or viral infections, platelet aggregation, cancer, transplant rejection or lung injuries
12/07/2010US7846479 poly(alpha-hydroxy acid), a polyhydroxy butyric acid, a polycaprolactone, a polyorthoester, a polyanhydride, or a polycyanoacrylate, formed using detergents; biologically active macromolecule adsorbed on surface
12/07/2010US7846458 Method and vaccine for treatment of pythiosis insidiosi in humans and lower animals
12/07/2010US7846451 Chimeric outermembrane polypeptide for use as tool in diagnosis and treatment of parasitic infection
12/07/2010US7846435 Humanized antibodies that recognize Verotoxin II and cell line producing same
12/07/2010CA2456029C Stable emulsion composition
12/07/2010CA2453263C Pharmaceutical compositions containing terbinafine and use thereof
12/07/2010CA2436409C Kappa opioid receptor ligands
12/07/2010CA2421114C 5-asa derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
12/07/2010CA2398335C Herpes virus strains
12/07/2010CA2323576C Bacteria attenuated by a non-reverting mutation in each of the aroc, ompf and ompc genes, useful as vaccines
12/02/2010WO2010138889A1 Peptides for the treatment of hcv infections
12/02/2010WO2010138791A1 Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c
12/02/2010WO2010138649A1 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010WO2010138488A1 Hepatitis c virus inhibitors
12/02/2010WO2010138419A2 Materials and methods for treating viral infections
12/02/2010WO2010138210A1 Methods of saponifying xanthophyll esters and isolating xanthophylls
12/02/2010WO2010137620A1 Phenoxyethylamine derivative
12/02/2010WO2010137594A1 Polypeptide having antibacterial activity and angiogenesis-inducing activity and wound-healing drug containing said polypeptide
12/02/2010WO2010137570A1 Anti-viral agent or an anti-cancer agent
12/02/2010WO2010136971A1 Ketolide compounds having antimicrobial activity
12/02/2010WO2010136841A2 Meganuclease variants cleaving the genome of a non-genomically integrating virus and uses thereof
12/02/2010WO2010136817A1 Heterocyclic urea derivatives and methods of use thereof
12/02/2010WO2010136804A1 Pyrimidine derivatives for use as antibiotics
12/02/2010WO2010135918A1 Didanosine precursor drug and its preparation method
12/02/2010WO2010135758A1 Use of anthracene derivatives as anti-infectives
12/02/2010WO2010115278A8 Methods and compositions for treating and preventing shiga toxin-producing escherichia coli infection
12/02/2010WO2010049438A3 Improved methods of using phosphoantigens for the treatment of diseases
12/02/2010WO2010049182A3 Treatment of retroviral reservoirs exploiting oxidative stress
12/02/2010WO2000045847A8 Novel mucosal delivery system
12/02/2010US20100305500 Hyaluronidase as an adjuvant for increasing the injection volume and dispersion of large diameter synthetic membrane vesicles containing a therapeutic agent
12/02/2010US20100305211 Gentle-Acting Skin-Disinfectants and Hydroalcoholic Gel Formulations
12/02/2010US20100305198 Cationic lipids
12/02/2010US20100305197 Conditionally Active Ribozymes And Uses Thereof
12/02/2010US20100305191 Rna interference mediated inhibition of adenosine a1 receptor (adora1) gene expression using short interfering rna
12/02/2010US20100305186 Methods for mediating gene suppression
12/02/2010US20100305185 Diagnostic method
12/02/2010US20100305182 Compounds and methods for modulating communication and virulence in quorum sensing bacteria
12/02/2010US20100305180 Inhibitors of ubiquitin e1
12/02/2010US20100305178 Pharmaceutical Composition
12/02/2010US20100305173 Hydroxyethylamino sulfonamide derivatives
12/02/2010US20100305147 Chemically modified small molecules
12/02/2010US20100305136 Quinolone analogs derivatized with sulfonic acid, sulfonate or sulfonamide
12/02/2010US20100305134 Specific inhibitors of pteridine reductase with antiparasitic action
12/02/2010US20100305123 Class of histone deacetylase inhibitors
12/02/2010US20100305119 Method for the treatment of anthrax infections
12/02/2010US20100305117 Substituted pteridines useful for the treatment and prevention of viral infections
12/02/2010US20100305115 Inhibitors of human immunodeficiency virus replication
12/02/2010US20100305104 Oxadiazole Diaryl Compounds
12/02/2010US20100305100 Methods for treating hepatitis c
12/02/2010US20100305097 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
12/02/2010US20100305096 Bicyclic pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305094 Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
12/02/2010US20100305084 Bicyclic indole-pyrimidine pi3k inhibitor compounds selective for p110 delta, and methods of use
12/02/2010US20100305081 Organo-gel formulations for therapeutic applications
12/02/2010US20100305073 Amide compounds as boosters of antivirals
12/02/2010US20100305072 Substituted Tetracycline Compounds
12/02/2010US20100305069 Oxazolidinone containing dimer compounds, compositions and methods to make and use
12/02/2010US20100305067 Antibacterial condensed thiazoles
12/02/2010US20100305065 Use of 4-(pyrrolidin-1-yl)quinoline compounds to kill clinically latent microorganisms
12/02/2010US20100305062 Use of alginate oligomers in combating biofilms
12/02/2010US20100305060 Nucleoside Prodrugs and Uses Thereof
12/02/2010US20100305055 Combinations of polyene fungicide with cationic surfactants
12/02/2010US20100305054 Concentrated aqueous azalide formulations
12/02/2010US20100305028 Cholesterol derivatives of inhibitors of viral fusion
12/02/2010US20100305027 Cyclic peptides comprising at least one aza-b3-aminoacyl residue and their uses
12/02/2010US20100305026 CD44V6 peptides as inhibitors of bacterial infections
12/02/2010US20100305025 Rnase a peptides, fragments and uses thereof
12/02/2010US20100303918 Compositions and methods for treating asthma and other lung disorders
12/02/2010US20100303899 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof
12/02/2010US20100303894 Pox viridae treatment
12/02/2010US20100303877 Controlled Release Hydrogel Films
12/02/2010US20100303864 Conserved and specific streptococcal genomes
12/02/2010US20100303863 Recombinant edwardsiella bacterium
12/02/2010US20100303861 Live Attenuated Vaccine Strain for Prevention of Tularemia
12/02/2010US20100303860 Compositions and methods for administration of vaccines against dengue virus
12/02/2010US20100303858 Chimeric HIV-1 Glycoproteins and Their Biological Applications
12/02/2010US20100303857 Development of a preventive vaccine for filovirus infection in primates
12/02/2010US20100303856 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)
12/02/2010US20100303852 Conjugation process for pnag and a carrier protein
12/02/2010US20100303850 Nanocarriers possessing components with different rates of release
12/02/2010US20100303849 Lipidated Vaccine against Dengue Virus Infection
12/02/2010US20100303848 Vaccination method
12/02/2010US20100303841 Adjuvant
12/02/2010US20100303840 Use of creatine or creatine analogs for the treatment of diseases of the nervous system
12/02/2010US20100303838 Vectors for multiple gene expression
12/02/2010US20100303831 Methods For The Treatment Of An Infectious Bacterial Disease With An Anti-Lactone Or Lactone Derived Signal Molecules Antibody
12/02/2010US20100303829 Hiv vpr-specific t cell receptors
12/02/2010US20100303828 Antibodies Against Human CD39 and Use Thereof for Inhibiting T Regulatory Cells Activity
12/02/2010US20100303826 Use of ADCC-Optimized antibodies for treating weak patients
12/02/2010US20100303823 Human monoclonal antibodies against interleukin 8 (il-8)
12/02/2010US20100303822 Polypeptides from non-typeable haemophilus influenzae
1 ... 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 ... 1798